Sunovion Secures US Marketing Rights for 3 Approved COPD Treatments
COPD, News
Sunovion Pharmaceuticals announced its entry into a license agreement with Novartis for exclusive U.S. commercialization rights to three U.S. Food and Drug Administration (FDA)- approved and long-term treatments for airflow obstruction in people with chronic ... Read more